Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:1645-1652, doi:10.1016/j.jacc.2007.11.081
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feit, F.
Right arrow Articles by Stone, G. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Feit, F.
Right arrow Articles by Stone, G. W.

Safety and Efficacy of Bivalirudin Monotherapy in Patients With Diabetes Mellitus and Acute Coronary Syndromes

A Report From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

Frederick Feit, MD, FACC*,*, Steven V. Manoukian, MD, FACC{dagger}, Ramin Ebrahimi, MD, FACC{ddagger}, Charles V. Pollack, MD§, E. Magnus Ohman, MD, FACC||, Michael J. Attubato, MD, FACC*, Roxana Mehran, MD, FACC# and Gregg W. Stone, MD, FACC#

* Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York
{dagger} Emory University School of Medicine, Atlanta, Georgia
{ddagger} University of California and the Greater Los Angeles VA Center, Los Angeles, California
§ Pennsylvania Hospital, Philadelphia, Pennsylvania
|| Duke University Medical Center, Durham, North Carolina
# Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York.


Figure 1
View larger version (37K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Subgroup Analyses: 30-Day End Points for Diabetic Patients by Treatment Group

The outcome data in subgroups, which are displayed as relative risk (RR) (solid squares) with 95% confidence interval (CI) (horizontal lines), are consistent with the data in the overall diabetic population for treatment with bivalirudin monotherapy versus heparin plus a glycoprotein IIb/IIIa inhibitor (GPI). CABG = coronary artery bypass graft; CKMB = creatine kinase isoenzyme MB fraction; CrCl = creatinine clearance; PCI = percutaneous coronary intervention.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement